US · Healthcare

Radient Technologies Inc (RDDTF)

Drug Manufacturers - Specialty & Generic

Radient Technologies Inc (RDDTF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RDDTF

P/E ratio

18.00

Radient Technologies Inc (RDDTF) — FAQ

What is RDDTF's P/E ratio?

The price-to-earnings (P/E) ratio for Radient Technologies Inc (RDDTF) is 18.00 (data as of 2026-05-23).

Does Radient Technologies Inc pay a dividend?

Dividend yield is not available in the current snapshot for Radient Technologies Inc (RDDTF). Check the MyAverix Finance app for the latest dividend data.

What sector is Radient Technologies Inc in?

Radient Technologies Inc (RDDTF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is RDDTF listed on?

RDDTF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)